Latest for Cold Agglutinin Disease
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial sites4 new sites opened for OM336 in Autoimmune Cytopenias (Phase 1, Lakefront Biotherapeutics West)ClinicalTrials.gov
More about Cold Agglutinin Disease
This coats the cells with a complement protein called C3b, and immune cells, mainly in the liver, then remove them from the blood. That removal outside the blood vessels is the main cause of red cell loss in stable disease. In severe disease and flares, complement can also go on to burst red cells inside the blood vessels.
Keep reading about Cold Agglutinin Disease
Patients experience hemolytic anemia with symptoms and severity exacerbated by cold exposure; even minor cold contact triggers hemolytic episodes. The disease presents with jaundice from bilirubin release and with hemolytic anemia with reduced hemoglobin and elevated reticulocyte count. Some people also have dark red or cola-colored urine from hemoglobin released into the blood (15% in one series).
Acrocyanosis (blue discoloration of extremities) and Raynaud phenomenon occur from red cell agglutination in peripheral circulation reducing blood flow. Episodes of acute hemolysis triggered by cold exposure can be severe and life-threatening.
In primary CAD, a small abnormal group of B cells in the bone marrow makes the cold agglutinin, so it is now seen as a low-grade bone marrow disorder. Doctors call the similar illness that follows an infection or an aggressive lymphoma cold agglutinin syndrome. Diagnosis is confirmed by direct antiglobulin (Coombs) test showing complement (C3, C3d) without IgG deposition (complement-only pattern diagnostic of CAD).
What are the symptoms of Cold Agglutinin Disease?
These are common symptoms of Cold Agglutinin Disease, and how strong they are varies from person to person.
- Hemolytic anemia and fatigue
- Symptoms worsened by cold exposure
- Jaundice and dark urine
- Acute hemolytic episodes in cold weather
- Acrocyanosis and Raynaud phenomenon
- Autoimmune complications
Who gets Cold Agglutinin Disease?
Mostly affects older adults. In a Norwegian population study of 86 people, the median age when the disease began was 67, and women outnumbered men nearly 2 to 1. In that study 90% had an abnormal light chain pattern in the bone marrow and 76% had signs of a slow-growing lymphoma.
A similar illness called cold agglutinin syndrome can follow infections such as Mycoplasma pneumoniae or Epstein-Barr virus, or an aggressive lymphoma.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Cold Agglutinin Disease?
There is currently 1 FDA-approved medication for Cold Agglutinin Disease.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Cold Agglutinin Disease treatment
Charity funds and drugmaker programs for Cold Agglutinin Disease, checked at the source.
- From a charity · The Assistance FundCold Agglutinin Disease (CAD) fundWaitlist
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
Every program and fund for Cold Agglutinin Disease, by insurance →
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
How Cold Agglutinin Disease is diagnosed
Caused by IgM autoantibodies; secondary CAD follows infection or lymphoproliferative disease. No germline gene test.
Trusted Cold Agglutinin Disease resources
Reputable organizations and medical references for learning more about Cold Agglutinin Disease, including disease registries, foundation resources, and clinical guidelines.
- NIH GARD - Cold Agglutinin Disease
- NORD - Cold Agglutinin Disease
- American Society of Hematology
- Berentsen S. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Front Immunol 2020
- Berentsen S et al. Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 2006